Samuel Strober

Samuel Strober (died February 11, 2022 (aged 8182)[1]) is a biomedical researcher and inventor best known for his work on the elimination of the need for life long immune suppressive drugs in organ transplant patients.[1]

Strober received his bachelor's degree from Columbia College[2] in 1961, and his MD from the Harvard Medical School [3] in 1966. He also studied at Massachusetts General[4] and Stanford University Hospitals[5] and the Sir William Dunn School of Pathology[6] at Oxford University.

He was chief of the Division of Immunology and Rheumatology[7][8] at the Stanford University School of Medicine (1979–1997); a co-founder of a biotechnology company, Dendreon, that developed the first FDA approved cancer vaccination; President of the Clinical Immunology Society (1996);[9] and Chairman of the Board of Directors of the La Jolla Institute for Allergy and Immunology.[10][11][12]He also co-founded Medeor Therapeutics.[13]

Personal life

His first wife is feminist economist Myra Strober, who decided to keep the Strober last name after she remarried.[14][15]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.